M. Martin

Publication List Details

Period

1882 - 2009

Number

57

Co-Authors

BrO measurements over the Eastern North-Atlantic (2009)

M. Martin, D. Pöhler, K. Seitz, R. Sinreich, U. Platt

The aim of the work presented here was to detect BrO in the marine boundary layer over the Eastern North-Atlantic by Multi AXis-Differential Optical Absorption Spectroscopy (MAX-DOAS) of scattered...

DOE’s Save Energy Now Assessments – Results and Lessons Learned from 450 Assessments Conducted in 2006-2007 (2008)

Martin, M., Wright, A.

Following a successful launch in 2006, the U.S. Department of Energy (DOE) continued to offer Save Energy Now (SEN) assessments to energy-intensive U.S. manufacturers in 2007. Through the Save Energy...

Effects of trail gradient on leaf tissue transport and load size selection in leaf-cutter ants (2008)

Lewis, O. T., Martin, M., Czaczkes, T. J.

Leaf-cutter ants in the genus Atta are frequent model organisms in studies of central-place foraging. Workers carry leaf fragments from the foraging site to the nest. Larger workers carry heavier...

Diffusion kinetics analysis of cation diffusion in YSZ and LSGM (2008)

Belova, I. V., Murch, G. E., Samuelis, D., Martin, M.

In this paper, we discuss different possible cation diffusion mechanisms in YSZ and LSGM. Monte Carlo simulations are also reported of tracer diffusivities in LSGM for a postulated cluster mechanism....

Collective and tracer diffusion via a defect cluster in LSGM (2007)

Belova, I. V., Murch, G. E., Samuelis, D., Martin, M.

It was recently shown by Schulz and co-workers that in doped lanthanum gallate: La₍₁₋x₎ SrxGa₍₁₋y₎ MgyO₍₃₋₍x₊y)/₂)(LSGM) the three cations: La, Sr and Mg have tracer...

Understanding intestinal cysteamine bitartrate absorption (2006)

Dohil, R, Fidler, M, Barshop, Bruce A, Gangoiti, J, Deutsch, R, Martin, M, ...

Objectives To test the hypothesis that a controlled-release preparation of cysteamine, with fewer daily administrations, would improve the quality of fife for patients with cystinosis. Study design A...

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial (2006)

Westhovens, R., Cole, J. C., Li, T., Martin, M., MacLean, R., Lin, P., ...

Objective. Rheumatoid arthritis (RA) patients who have inadequate response to anti-tumour necrosis factor (TNF) therapy currently have treatment options that are limited and less than optimal in...

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial (2006)

Westhovens, R., Cole, J. C., Li, T., Martin, M., MacLean, R., Lin, P., ...

Objective. Rheumatoid arthritis (RA) patients who have inadequate response to anti-tumour necrosis factor (TNF) therapy currently have treatment options that are limited and less than optimal in...

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial (2006)

Westhovens, R., Cole, J. C., Li, T., Martin, M., MacLean, R., Lin, P., ...

Objective. Rheumatoid arthritis (RA) patients who have inadequate response to anti-tumour necrosis factor (TNF) therapy currently have treatment options that are limited and less than optimal in...

Survival among hospital in-patients with troponin T elevation below levels defining myocardial infarction (2005)

Cook, G., Taylor, D., France, M., Burrows, G., Manning, E., Lyratzopoulos, G., ...

Background: Cardiac troponin T (cTnT) has an accepted place in the management of patients presenting with suspected acute coronary syndrome (ACS). Uncertainty remains about the significance and...

Survival among hospital in-patients with troponin T elevation below levels defining myocardial infarction (2005)

Cook, G., Taylor, D., France, M., Burrows, G., Manning, E., Lyratzopoulos, G., ...

Background: Cardiac troponin T (cTnT) has an accepted place in the management of patients presenting with suspected acute coronary syndrome (ACS). Uncertainty remains about the significance and...

Evolution of the meiotic prophase and of the chromosome pairing process during human fetal ovarian development (2005)

Roig, I., Robles, P., Garcia, R., Martin, M., Egozcue, J., Cabero, Ll., ...

BACKGROUND: Studies on human oocytes in prophase I are limited due to the difficulty in obtaining the sample. However, a complete study of meiotic prophase evolution and the homologue pairing process...

Evolution of the meiotic prophase and of the chromosome pairing process during human fetal ovarian development (2005)

Roig, I., Robles, P., Garcia, R., Martin, M., Egozcue, J., Cabero, Ll., ...

BACKGROUND: Studies on human oocytes in prophase I are limited due to the difficulty in obtaining the sample. However, a complete study of meiotic prophase evolution and the homologue pairing process...

Epirubicin-cyclophosphamide adjuvant chemotherapy plus tamoxifen administered concurrently versus sequentially: randomized phase III trial in postmenopausal node-positive breast cancer patients. A GEICAM 9401 study (2004)

Pico, C., Martin, M., Jara, C., Barnadas, A., Pelegri, A., Balil, A., ...

Background: A prospective randomized clinical trial was implemented to assess whether the concomitant or the sequential addition of tamoxifen to chemotherapy provides improved clinical benefit in the...

Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines (2003)

Martin, M., Spielmann, M., Namer, M., DuBois, A., Unger, C., Dodwell, D., ...

Background: To assess antitumor activity and toxicity of pemetrexed in metastatic breast cancer (MBC) patients previously treated with anthracyclines. Patients and methods: Seventy-seven MBC patients...

Cardiac function following combination therapy with paclitaxel and doxorubicin: An analysis of 657 women with advanced breast cancer (2001)

Gianni, L., Dombernowsky, P., Sledge, G., Martin, M., Amadori, D., Arbuck, S. G., ...

Background: To determine the cardiotoxicity of paclitaxel (T) plus doxorubicin (A) combination therapy in women with advanced breast cancer. To define a dose range of A for use in AT. Patients and...

Systemic lupus erythematosus and rheumatoid arthritis patients differ from healthy controls in their cytokine pattern after stress exposure (2001)

Jacobs, R., Pawlak, C. R., Mikeska, E., Meyer-Olson, D., Martin, M., Heijnen, C. J., ...

Objective. To study whether patients with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) differ from healthy individuals in their immune responses to acute...

Paclitaxel plus vinorelbine: An active regimen in metastatic breast cancer patients with prior anthracycline exposure (2000)

Martin, M., Lluch, A., Casado, A., Garcia Carbonero, I., De Paz, L., Esteban, C., ...

Purpose: To evaluate the anti-tumour activity and tolerance of the combination of paclitaxel plus vinorelbine in metastatic breast cancer (MBC) patients previously treated with anthra-cyclines....

Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer (1996)

Dirix, L. Y., Vermeulen, P. B., Hubens, G., Benoy, I., Martin, M., De Pooter, C., ...

Background: The development of new microvessels in the surrounding stroma is a prerequisite for tumour progression. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF)...

Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy (1994)

García-Conde, J., Lluch, A., Martin, M., Casado, A., Gervasio, H., De Oliveira, C., ...

Purpose The study investigated the therapeutic effect of single-agent IV weekly vinorelbine (Navelbine®, Pierre Fabre Oncologie, Boulogne, France) a semi-synthetic vinca-alkaloid, in women who had...

Neoadjuvant combination of carboplatin and 5-FU in head and neck cancer: A randomized study (1992)

Gehanno, P., Depondt, J., Peynegre, R., Peytral, C., Martin, M., Baillet, F., ...

A prospective, randomized, multicenter study of patients with oropharyngeal and pharyngolaryngeal tumors compared locoregional treatment alone with neoadjuvant chemotherapy with...

Deterministic Late Effects of Skin Irradiation: In Vitro Studies of Experimental Radiation Fibrosis (1991)

Martin, M., Lafuma, C., Sabatier, L., Crechet, F., Pinton, P., Daburon, F.

After radiotherapy or radiation accidents, large doses of gamma irradiation can induce necrosis and fibrosis, and secondary cancers are occasionally observed. The identity of the target cells in such...

Effect of captan on DNA synthesis in the liver and testes of rats (1980)

Decloitre, F., Martin, M.

Rats were fed a diet containing 0.3% (w/w) captan for 2, 4 and 12 weeks and compared with controls, and with rats fed 0.02% (w/w) N-2-acetylamino-fluorene (AAF). Cell loss was...

Effects of cimetidine and indomethacin on the growth of dimethylhydrazine-induced or transplanted intestinal cancers in the rat.

Caignard, A., Martin, M., Reisser, D., Thomas, B., Martin, F.

The effects of cimetidine and indomethacin on the growth of dimethylhydrazine induced or transplanted intestinal tumours in the rat have been studied. Cimetidine is a histamine type 2 receptor...

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients.

Dirix, L. Y., Vermeulen, P. B., Pawinski, A., Prové, A., Benoy, I., De Pooter, C., ...

The concentration of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) was determined in the serum of 90 untreated and 42 treated metastatic cancer patients,...

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial

Chan, A, Martin, M, Untch, M, Gil, M G, Guillem-Porta, V, Wojtukiewicz, M, ...

The aim of this international phase II trial was to determine the efficacy and safety profile of weekly vinorelbine plus trastuzumab as first-line chemotherapy for women with HER 2-overexpressing...

Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy

Campone, M, Cortes-Funes, H, Vorobiof, D, Martin, M, Slabber, C F, Ciruelos, E, ...

To evaluate the single agent activity, pharmacokinetics and tolerability of the novel tubulin targeted agent vinflunine (VFL) (320 mg m−2 q 21 days) as second-line chemotherapy in patients with...